Keywords: vernalis, unveils, new, parkinson, disease, drug, uk

Vernalis unveils new Parkinson's disease drug

Article | 14 January 2002

Print This

Vernalis of the UK says it has selected a lead development compound inits adenosine A2A receptor antagonist research program ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in